Jazz Pharmaceuticals JAZZ Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Property, Plant, and Equipment at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's payments to acquire property, plant, and equipment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's payments to acquire property, plant, and equipment?
- Jazz Pharmaceuticals (JAZZ) reported payments to acquire property, plant, and equipment of $19.7M in Q1 2026.
- How has Jazz Pharmaceuticals's payments to acquire property, plant, and equipment changed year-over-year?
- Jazz Pharmaceuticals's payments to acquire property, plant, and equipment increased by 41.7% year-over-year, from $13.9M to $19.7M.
- What is the long-term trend for Jazz Pharmaceuticals's payments to acquire property, plant, and equipment?
- Over 3 years (2021 to 2025), Jazz Pharmaceuticals's payments to acquire property, plant, and equipment has grown at a 28.6% compound annual growth rate (CAGR), from $27.64M to $58.75M.
- What does payments to acquire property, plant, and equipment mean?
- Cash spent on buying physical infrastructure and equipment.
- How do you interpret payments to acquire property, plant, and equipment?
- Consistent levels indicate stable maintenance, while spikes suggest capacity expansion or facility upgrades.
- How does payments to acquire property, plant, and equipment compare across companies?
- Standard metric for all manufacturing and industrial companies.